NCT04018820

Brief Summary

Eleven men with myotonic dystrophy type 1 (DM1) underwent a 12-week lower-limb strength training program. The training program consisted of 3 series of 6 to 8 maximal repetitions of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. Training sessions were closely supervised and took place twice a week. It is hypothesised that the training program will induce muscular hypertrophy despite the genetic defect. The training program should also have positive effects on function. The participants were evaluated at baseline, week 6, week 12, month 6 and month 9 to see the effects of the training program and if these effects are maintained over time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2018

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

July 9, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 15, 2019

Completed
Last Updated

December 15, 2021

Status Verified

December 1, 2021

Enrollment Period

12 months

First QC Date

July 9, 2019

Last Update Submit

December 6, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in maximal isometric muscle strength of the knee extensors

    Changes in maximal isometric muscle strength of the knee extensors measured by quantified muscle testing using a handheld dynamometer

    At baseline, week 6, week 12, month 6 and month 9

Secondary Outcomes (23)

  • Changes in maximal isometric muscle strength of the knee flexors

    At baseline and week 12

  • Changes in maximal isometric muscle strength of the hip flexors

    At baseline and week 12

  • Changes in maximal isometric muscle strength of the hip extensors

    At baseline and week 12

  • Changes in maximal isometric muscle strength of the ankle dorsiflexors

    At baseline and week 12

  • Changes in 1-repetition maximum strength of the leg extension exercise

    At baseline, week 6 and week 12

  • +18 more secondary outcomes

Study Arms (1)

Training program

EXPERIMENTAL
Other: Training program

Interventions

12-week strength training program of the lower limbs consisting of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. All exercises were performed between 6 and 8 maximal repetitions.

Training program

Eligibility Criteria

Age30 Years - 65 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • DM1 diagnosis must be confirmed by genetic analysis;
  • Male gender, aged between 30 and 65 years old;
  • Be able to walk without assistance;
  • Consent of the neurologist must be given to participate in this study;
  • Must reside in the Saguenay-Lac-St-Jean region;
  • Subjects must be able to give their consent freely and voluntarily.

You may not qualify if:

  • Patients with any other form of muscular dystrophy are excluded;
  • Any contraindication for strenuous exercise or muscle biopsy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe de recherche interdisciplinaire sur les maladies neuromusculaires

Saguenay, Quebec, G7X 7X2, Canada

Location

MeSH Terms

Conditions

Myotonic Dystrophy

Condition Hierarchy (Ancestors)

Muscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesMyotonic DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesNervous System DiseasesNeuromuscular DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Elise Duchesne, Ph.D.

    Université du Québec à Chicoutimi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Most outcomes where not masked, however the outcome assessor was masked for all muscle biopsy analysis: while analysing the muscle biopsy outcomes, the outcome assessor did not know if it was from baseline or from after the training program.
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Model Details: Participants had to complete a 12-week strength training program and return to their normal activities for the following 6 months after the end of the training program
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Sponsor-Investigator

Study Record Dates

First Submitted

July 9, 2019

First Posted

July 15, 2019

Study Start

July 1, 2017

Primary Completion

June 22, 2018

Study Completion

June 22, 2018

Last Updated

December 15, 2021

Record last verified: 2021-12

Locations